2015
DOI: 10.1186/s13048-015-0131-9
|View full text |Cite
|
Sign up to set email alerts
|

Use of aromatase inhibitors in practice of gynecology

Abstract: PurposeThe conversion of androgens into estrogens by aromatase is called aromatization and is inhibited by aromatase inhibitors (AIs). The aim of this article is to evaluate the use of aromatase inhibitors in gynecological diseases such as endometriosis, leiomyoma, estrogen- dependent gynecologic neoplasia and infertility.MethodsThis is a review of literature combined with experience and use of aromatase ınhıbıtors ın practıce of gynecology.ConclusionAIs are promising agents in treatment of estrogen dependent … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
17
0
1

Year Published

2016
2016
2023
2023

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 34 publications
(18 citation statements)
references
References 73 publications
0
17
0
1
Order By: Relevance
“…This might be attributable to the complete clearance of LTZ after approximately 10–12 days from its last dose (Usluogullari et al . ). However, it may take a longer time to downregulate the inflammatory cytokines produced in the tubo‐ovarian milieu.…”
Section: Discussionmentioning
confidence: 97%
See 2 more Smart Citations
“…This might be attributable to the complete clearance of LTZ after approximately 10–12 days from its last dose (Usluogullari et al . ). However, it may take a longer time to downregulate the inflammatory cytokines produced in the tubo‐ovarian milieu.…”
Section: Discussionmentioning
confidence: 97%
“…The inhibition of aromatization by LTZ results in a local increase in androgens that potentiate the follicular sensitivity to FSH (Usluogullari et al . ). The latter receptors are upregulated in OSE overlying large follicles (Saddick ), suggesting that gonadotropins may have a differential local growth‐stimulating effect (Ng & Barker ).…”
Section: Discussionmentioning
confidence: 97%
See 1 more Smart Citation
“…Aromatase is found in several tissues including the ovaries, liver, breasts, brain, and adipose tissue [58][59][60].…”
Section: Vitamin D and Steroidogenesismentioning
confidence: 99%
“…Fratura de fragilidade ≤ 50 59 Terapia de privação de androgénios [60][61][62] Imobilização prolongada e paralisia [63][64] Glucocorticoides 65 Historial de quedas [5][6]8,11,18 Anticonvulsantes 66 Anorexia nervosa [67][68] Análogos da hormona libertadora de gonadotropinas (GnRH) 69-71 Deficiência de cálcio e de vitamina D 5,8,[72][73] Inibidores de aromatase [74][75][76][77][78] Absorção intestinal 8,79 Terapia antirretroviral 73,80 Artrite reumatoide 81 Hiperparatireoidismo [82][83] QUADRO III. Condições/doenças e tratamentos com impacto na DMO, conforme estabelecido em revisões sistemáticas da literatura e/ou em meta-análises documentos inibidores seletivos de recaptação de serotonina; Tamoxifen®; tiazolidinedionas hiazolidinedionas T (como Actos®); hormonas da tiroide (em excesso).…”
Section: Doentes Com As Seguintes Condições/doençasunclassified